Stability indicating ion-pair HPLC method for the determination of risedronate in a commercial formulation

Journal of Liquid Chromatography and Related Technologies

Volumn 27, Issue 17, 2004, Pages 2799-2813

  Aluoch, Austin ^a   Tatini, Radhakrishna ^a   Parsons, Donald M ^b   Sadik, Omowunmi ^a  

^a BINGHAMTON UNIVERSITY   (United States)

^b PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

Actonel tablets; Assay; Eclipse XDB C18; Ion pair HPLC; Risedronate; Stability indicating; UV detection; Validation

Indexed keywords

CONCENTRATION (PROCESS); LIQUID CHROMATOGRAPHY; SEPARATION; SODIUM;

LIMIT OF DETECTION (LOD); STANDARD DEVIATION; TETRABUTYLAMMONIUM; ULTRAVIOLET DETECTION;

DRUG PRODUCTS;

AMMONIUM DERIVATIVE; RISEDRONIC ACID; TETRABUTYLAMMONIUM PHOSPHATE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; DRUG DETERMINATION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ION PAIR CHROMATOGRAPHY;

EID: 5144233300     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1081/JLC-200029351     Document Type: Article

References (14)

1. Mitchell, D.Y.; Eusebio, R.A.; Dunlap, L.E.; Pallone, K.A.; Nesbit, J.D.; Russell, D.A.; Clay, M.E.; Bekker, P.J. Risedronate gastrointestinal absorption is independent of site and rate of administration. Pharm. Res. 1998, 15, 228.
2. Mitchell, D.Y.; Heise, M.A.; Pallone, K.A.; Clay, M.E.; Nesbit, J.D.; Russell, D.; Melson, C. The effect of dosing regimen on the pharmacokinetics of risedronate. Br. J. Clin. Pharmacol. 1999, 48, 536-542.
3. Vallano, P.T.; Shugarts, S.B.; Kline, W.F.; Woolf, E.J.; Matuszewski, B.K. Determination of risedronate in human urine by column-switching ion-pair high performance liquid chromatography with ultraviolet detection. J. Chromatogr. B 2003, 794, 23-33.
4. Fels, J.-P.; Guyonnet, J.; Berger, Y.; Cautreels, W. Determination of (4-chlorophenyl)thiomethylene bisphosphonic acid, a new bisphosphonate, in biological fluids by high performance liquid chromatography. J. Chromatogr. 1988, 430, 73-79.
5. Usui, T.; Watanabe, T.; Higuchi, S. Determination of a new bisphosphonate, YM175, in plasma, urine and bone by high performance liquid chromatography with electrochemical detection. J. Chromatogr. 1992, 584, 213-220.
6. Hartigh, J.D.; Langebroek, R.; Vermeij, P. Ion-exchange liquid chromatographic analysis of bisphosphonates in pharmaceutical preparations. J. Pharm. Biomed. Anal. 1993, 11, 977-983.
7. Quattrocchi, O.; Frisardi, L.; Iglesias, M.; Noya, M.; Caputto, M.; Ferraris, D.; Siliprandi, D.; Piccinni, E. Ion exchange chromatographic determination of olpadronate, phosphate, phosphite, chloride, and methanesulfonic acid. J. Pharm. Biomed. Anal. 2001, 24, 1011-1018.
8. Pettersson, K.J.; Nordgren, T.; Westerlund, D. Determination of phosphonoformate (foscarnet) in biological fluids by ion-pair reversed-phase liquid chromatography. J. Chromatogr. 1989, 488, 447-455.
9. Kwong, E.; Chiu, A.M.Y.; McClintock, S.A.; Cotton, M.L. HPLC analysis of an amino bisphosphonate in pharmaceutical formulations using postcolumn derivatization and fluorescence detection. J. Chromatogr. Sci. 1990, 28, 563-566.
10. Determination of Polyvalent Anions by Ion Chromatography; Dionex Corporation: Sunnyvale, California, 1983.
11. Daley-Yates, P.T.; Gifford, L.A.; Hoggarth, C.R. Assay of 1-hydroxy-3-aminopropylidene-1,1-bisphosphonate and related bisphosphonates in human urine and plasma by high performance ion chromatography. J. Chromatogr. 1989, 490, 329-338.
12. International conference on Harmonization, Draft Guideline on Validation Procedures, Definitions and Terminology, 1995, 60, 11260, 1 March.
13. Bisaz, S.; Felix, R.; Fleisch, H. Quantitative determination of ethane-1-hydroxy-1,1-diphosphonate in urine and plasma. Clin. Chim. Acta 1975, 65, 299-307.
14. Christian, G.D. Analytical Chemistry, 5th Ed; John Wiley and Sons: New York, 1994; 563.